Provided by Tiger Fintech (Singapore) Pte. Ltd.

Boston Scientific

99.36
-1.4400-1.43%
Post-market: 99.360.00000.00%19:56 EDT
Volume:7.40M
Turnover:733.40M
Market Cap:146.96B
PE:79.49
High:100.42
Open:99.94
Low:98.02
Close:100.80
Loading ...

Company Profile

Company Name:
Boston Scientific
Exchange:
NYSE
Establishment Date:
1979
Employees:
53000
Office Location:
300 Boston Scientific Way,Marlborough,Massachusetts,United States
Zip Code:
01752-1234
Fax:
- -
Introduction:
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Directors

Name
Position
Michael F. Mahoney
CEO, Chairman of the Board
Charles J. Dockendorff
Independent Director
David S. Wichmann
Independent Director
Edward J. Ludwig
Independent Director
Ellen M. Zane
Independent Director
Jessica L. Mega
Independent Director
John E. Sununu
Independent Director
Susan E. Morano
Independent Director
Yoshiaki Fujimori
Independent Director
Cheryl Pegus
Director
David C. Habiger
Director

Shareholders

Name
Position
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
Vance R. Brown
Senior Vice President,General Counsel,Corporate Secretary
Arthur C. Butcher
Executive Vice President and Group President,MedSurg and Asia Pacific
Eric Thepaut
Executive Vice President and President, Europe,Middle East and Africa
Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
John B. Sorenson
Executive Vice President,Global Operations
Joseph M. Fitzgerald
Executive Vice President and Group President,Cardiology
Michael F. Mahoney
CEO, Chairman of the Board
Wendy Carruthers
Executive Vice President,Human Resources